Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer-Reference-Cited by-同舟云学术

Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer

Published:2015-06-04 Issue:1 Volume:14 Page:
ISSN:1476-4598
Container-title:Molecular Cancer
language:en
Short-container-title:Mol Cancer

Author:

Min Hye-Young,Yun Hye Jeong,Lee Ji-Sun,Lee Hyo-Jong,Cho Jaebeom,Jang Hyun-Ji,Park Shin-Hyung,Liu Diane,Oh Seung-Hyun,Lee J. Jack,Wistuba Ignacio I.,Lee Ho-Young

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12943-015-0392-3.pdf

Reference53 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11–30.

3. Dempke WC, Suto T, Reck M. Targeted therapies for non-small cell lung cancer. Lung Cancer. 2010;67:257–74.

4. Camidge DR, Pao W, Sequist LV. Acquired resistance to TKIs in solid tumours: learning from lung cancer. Nat Rev Clin Oncol. 2014;11:473–81.

5. Morgillo F, Woo JK, Kim ES, Hong WK, Lee HY. Heterodimerization of insulin-like growth factor receptor/epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of erlotinib. Cancer Res. 2006;66:10100–11.

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breed of origin analysis in genome-wide association studies: enhancing SNP-based insights into production traits in a commercial Brangus population;BMC Genomics;2024-07-01

2. PRKCSH contributes to TNFSF resistance by extending IGF1R half-life and activation in lung cancer;Experimental & Molecular Medicine;2024-01-10

3. Role of exosomes in prostate cancer and male fertility;Drug Discovery Today;2023-11

4. Costs and Causes of Oncology Drug Attrition With the Example of Insulin-Like Growth Factor-1 Receptor Inhibitors;JAMA Network Open;2023-07-28

5. Metabolic Reprogramming Driven by IGF2BP3 Promotes Acquired Resistance to EGFR Inhibitors in Non–Small Cell Lung Cancer;Cancer Research;2023-04-16